【24h】

Viral hepatitis and liver cancer

机译:病毒性肝炎和肝癌

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hepatitis B and C viruses are a global health problem causing acute and chronic infections that can lead to liver cirrhosis and hepatocellular carcinoma (HCC). These infections are the leading cause for HCC worldwide and are associated with significant mortality, accounting for more than 1.3 million deaths per year. Owing to its high incidence and resistance to treatment, liver cancer is the second leading cause of cancer-related death worldwide, with HCC representing approximately 90% of all primary liver cancer cases. The majority of viral-associated HCC cases develop in subjects with liver cirrhosis; however, hepatitis B virus infection can promote HCC development without prior end-stage liver disease. Thus, understanding the role of hepatitis B and C viral infections in HCC development is essential for the future design of treatments and therapies for this cancer. In this review, we summarize the current knowledge on hepatitis B and C virus hepatocarcinogenesis and highlight direct and indirect risk factors.
机译:乙型肝炎和C病毒是一种全球健康问题,导致急性和慢性感染,可导致肝硬化和肝细胞癌(HCC)。这些感染是全球HCC的主要原因,与大量死亡率有关,每年占130多万人死亡。由于其发病率高和耐药性,肝癌是全世界癌症相关死亡的第二个主要原因,HCC占所有原发性肝癌病例的约90%。大多数病毒相关的HCC病例在肝硬化的受试者中发展;然而,乙型肝炎病毒感染可以促进HCC发育,而无需先前的终末期肝病。因此,了解乙型肝炎和C病毒感染在HCC开发中的作用对于未来的治疗和治疗癌症的设计至关重要。在审查中,我们总结了目前关于乙型肝炎和C病毒肝癌发生的知识,并突出直接和间接风险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号